Odaily Planet Daily reports: Paul Conyngham, founder of an Australian AI consulting firm, posted on X detailing the complete technical process of designing a personalized mRNA cancer vaccine for his pet dog using multiple AI chatbots. The dog was diagnosed with malignant mast cell tumor in May 2024, after which approximately 300 GB of data was obtained through whole-genome and RNA sequencing. Leveraging the collaborative efforts of ChatGPT, Gemini, and Grok, the team performed target screening, protein structure modeling, and vaccine sequence design, ultimately identifying a c-KIT gene mutation and selecting seven novel antigen targets.
The vaccine was developed by a research team affiliated with the University of New South Wales and administered by the School of Veterinary Science at the University of Queensland. The comprehensive treatment regimen combined an mRNA vaccine, a tyrosine kinase inhibitor, and a PD-1 inhibitor, with dosing timing optimized via AI assistance. Three months after treatment began in December 2025, some tumors showed reduction, but residual non-responsive lesions required surgical intervention. Experts emphasized that this case represents a single individual treatment and does not constitute a generalizable medical conclusion.